| Melanoma risk in patients treated with biologic therapy for common inflammatory diseases: a systematic review and meta-analysis S Esse, KJ Mason, AC Green, RB Warren JAMA dermatology 156 (7), 787-794, 2020 | 58 | 2020 |
| Baseline characteristics of patients registering to the British Association of Dermatologists Biologics and Immunomodulators Register stratified by duration of psoriasis at the … C Reid, KJ Mason, S Esse, K McElhone, M Lunt, L Cordingley, ... BRITISH JOURNAL OF DERMATOLOGY 181, 2019 | 1 | 2019 |
| P072 Risk of incident cancer, excluding keratinocyte carcinoma, in patients with psoriasis treated with biologic therapy: a prospective cohort study from the British … S Esse, O Alabas, K Mason, S Ryan, NJ Reynolds, C Smith, A Green, ... British Journal of Dermatology 191 (Supplement_1), i48-i48, 2024 | | 2024 |
| O05 Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and … S Esse, O Alabas, K Mason, S Ryan, NJ Reynolds, C Smith, C Bunker, ... British Journal of Dermatology 191 (Supplement_1), i3-i4, 2024 | | 2024 |
| An Investigation into the Risk of Cancer in Patients with Psoriasis Treated with Biologic Therapy S Esse PQDT-Global, 2023 | | 2023 |
| The risk of melanoma in patients with immune-mediated inflammatory diseases exposed to biological therapies: systematic review and meta-analysis S Esse, KJ Mason, AC Green, RB Warren | | 2019 |
